US OptionsDetailed Quotes
FCN250117C130000
- 0.00
- 0.000.00%
15min DelayClose Jan 3 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest130.00Strike Price0.00Turnover71.68%IV-32.15%PremiumJan 17, 2025Expiry Date61.59Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9985Delta0.0002Gamma3.10Leverage Ratio-0.0197Theta0.0454Rho3.10Eff Leverage0.0018Vega
FTI Consulting Stock Discussion
Sign in to post a comment
$LumiraDx (LMDXF.US)$ If Roche $ROCHE HOLDING AG (RHHBY.US)$ were to announce a 1:1 conversion rate into RHHBY for us prematurely it could cause a negative sentiment to rhhby knowing that information. FTI CONSULTING $FTI Consulting (FCN.US)$ could be in the thought process of well if we scare Lumiradx shareholders out of their shares maybe Roche will pay us more. I know one thing for sure though these shady deals will NOT exist in Trump/Kash world.
5
1
FTI Consulting's strategic appointment of Ms. Irastorza is aimed at bolstering its Litigation & Disputes Resolution practice, especially in the energy sector. Her vast experience in handling complex energy sector issues is anticipated to aid the firm's clients amidst industry transformations.
1
Carlyn Taylor of FTI Consulting praises Jagtap's ability to use his unique background to help clients create value. Jagtap emphasizes the firm's commitment to value creation for their private equity clients.
1
FTI Consulting's clients are expected to greatly benefit from the addition of experienced professionals, as they navigate new technologies and strategies in an increasingly technical landscape. The company's focus on digital transformation is seen as a key driver for revenue growth and operational efficiency.
FTI Consulting's high P/E ratio may be due to investor optimism, but average growth expectations and potential difficulties in achieving further gains could weigh on the share price. The current high P/E ratio may not be justified.
FTI Consulting's laudable performance includes significant reinvestment and decent earnings growth. Despite this, its growth is only moderate compared to its industry peers. Future forecasts expect an acceleration in the company's earnings.
Brian Flynn expressed anticipation for innovative solutions from Maddoux and Marston amid healthcare uncertainties. Maddoux also expressed confidence in FTI Consulting's capability to support clients.
Substantial insider selling at FTI Consulting signals a potential concern about the company's future. Despite profitability and growth, the lack of insider buying could indicate a lack of confidence.
FTI Consulting has seen a 26% annual increase in share price, exceeding its EPS growth. Market sentiment towards the business is higher than it was 5 years ago, possibly due to its robust growth. Given recent performance improvements and signs of real business momentum, it might be a great time to look closer into the company.
No comment yet
72464536 : I hope you’re right!!!!